• Inaccurate Forecasting Is Here To Stay: Focus on Managing Risk Instead
    Inaccurate Forecasting Is Here To Stay: Focus on Managing Risk Instead

    The single most important factor influencing pharmaceutical and biopharmaceutical decisions is demand forecasting. Forecasts impact decisions regarding capital cost, outsourcing for product commercialization, and many other critical aspects of production. It’s no secret that drug forecasts are notoriously incorrect, and often by large margins. John LaMattina, former president of Pfizer Global R&D, foresees no improvement in forecasting accuracy.1 How then, do companies minimize risk?

More From Featured Articles


  • FDA Approves Genentech’s Xolair (omalizumab) For Allergic Asthma In Children

    Genentech, a member of the Roche Group , recently announced that the U.S. Food and Drug Administration (FDA) approved Xolair (omalizumab) to treat moderate to severe persistent asthma in children six to 11 years of age, who have had a positive skin test or in vitro reactivity to an airborne allergen and have symptoms that are inadequately controlled with inhaled corticosteroids4



Fume Hoods Fume Hoods
The ChemGARD and ChemGARD-RI fume hoods use continuous a flow bypass design, which is
Inhibitor Cocktails
Sigma Inhibitor Cocktails are designed for protein isolation research and offer effective protease or phosphatase inhibition...
Mobilespin Mobilespin
Models 126, PS126 and 128
Catalog of Supplies and Services Catalog of Supplies and Services
The Production Supplies and Services Catalog offers over 9,000 products to protect people, products, and processes in cleanrooms, controlled environments, and production areas...
Lipid Library
The Screen-Well Bioactive Lipid Library enables researchers to rapidly screen and identify ligands for orphan receptors...
Drug Process Development Drug Process Development

Althea’s complete range of drug Process Development capabilities offers the tools to address your needs. We develop processes for producing small quantities of proteins for early testing or establish robust, reliable and scalable processes that enable a strong commercial advantage. Althea also provides access to a proprietary drug delivery platform, called Crystalomics® technology, for the development of alternative drug delivery formulations of second generation drug substances.

More Featured Products


Best Practices in CMC Dossier Preparation – Facing Tough Challenges July 28, 2016
Special Time for EU and US Participants - 10:30am-12pm EDT, Online Training
Preparing for - and Surviving - a FDA Medical Device Inspection July 28, 2016
1pm-2:30pm EDT, Online Training
More Upcoming Courses